{"meshTagsMajor":["Mutation"],"meshTags":["Carcinoma, Non-Small-Cell Lung","Erlotinib Hydrochloride","Female","Humans","Lung Neoplasms","Male","Mutation","Receptor, Epidermal Growth Factor"],"meshMinor":["Carcinoma, Non-Small-Cell Lung","Erlotinib Hydrochloride","Female","Humans","Lung Neoplasms","Male","Receptor, Epidermal Growth Factor"],"organisms":["6755"],"publicationTypes":["Comment","Journal Article"],"title":"Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials.","pubmedId":"26720042"}